Skip to main content
logo
Amicus Therapeutics, Inc. (FOLD)
Apr 27, 2026 - FOLD was delisted (reason: acquired by BMRN)
14.49
0.00 (0.00%)
Inactive · Last trade price on Apr 24, 2026

Amicus Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-27.11-56.11-151.58-236.57-250.46
Depreciation & Amortization
7.468.557.875.346.21
Other Amortization
2.572.262.622.632.49
Asset Writedown & Restructuring Costs
-1.149.212.7318.18-
Stock-Based Compensation
87.4184.9186.0876.5157.84
Other Operating Activities
3.5916.2331.197.2110.37
Change in Accounts Receivable
-5.86-19.48-20.11-17.33-8.19
Change in Inventory
-111.48-73.65-44.61-5.34-7.79
Change in Accounts Payable
82.78-16.5249.2-6.387.43
Change in Other Net Operating Assets
-5.0710.71-32.46-10.83-20.39
Operating Cash Flow
33.15-33.89-69.09-166.58-202.49
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-3.3-3.55-7.44-3.77-3.88
Sale of Property, Plant & Equipment
---3.41-
Investment in Securities
-43.142.99105.592.6782.65
Investing Cash Flow
-46.43-0.5698.0692.3278.76

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--387.36--
Long-Term Debt Repaid
-0.27-0.1-408.32-0.28-0.48
Net Debt Issued (Repaid)
-0.27-0.1-20.96-0.28-0.48
Issuance of Common Stock
19.2127.24103.214.31229.21
Repurchase of Common Stock
-18.32-22.03-17.92-11.49-15.01
Other Financing Activities
---2.65--1.65
Financing Cash Flow
0.615.1261.68-7.46212.07

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
13.28-4.036.31-14.62-5.05
Net Cash Flow
0.6-33.3696.96-96.3483.29

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
29.85-37.44-76.53-170.34-206.38
Free Cash Flow Growth
-----
Free Cash Flow Margin
4.71%-7.09%-19.16%-51.74%-67.55%
Free Cash Flow Per Share
0.10-0.12-0.26-0.59-0.76
Levered Free Cash Flow
47.845.41-25.89-94.23-84.97
Unlevered Free Cash Flow
74.1234.142.84-73.66-67.16

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
43.6158.9636.0934.3630.47
Cash Income Tax Paid
14.898.218.531.6120.03
Change in Working Capital
-39.63-98.94-47.99-39.88-28.94
SEC Filings: 10-K · 10-Q